Synergy Health Plc’s “Sell” Rating Reaffirmed at Canaccord Genuity (SYR)
Synergy Health Plc (LON:SYR)‘s stock had its “sell” rating reaffirmed by Canaccord Genuity in a research note issued on Friday, AnalystRatings.Net reports. They currently have a GBX 987 ($16.62) price target on the stock. Canaccord Genuity’s price target would indicate a potential downside of 20.96% from the company’s current price.
Synergy Health Plc (LON:SYR) opened at 1223.00 on Friday. Synergy Health Plc has a 52-week low of GBX 991.00 and a 52-week high of GBX 1437.00. The stock has a 50-day moving average of GBX 1292. and a 200-day moving average of GBX 1226.. The company’s market cap is £716.7 million.
A number of other analysts have also recently weighed in on SYR. Analysts at Investec reiterated a “buy” rating on shares of Synergy Health Plc in a research note on Friday. They now have a GBX 1,450 ($24.42) price target on the stock. Separately, analysts at Numis Securities Ltd reiterated an “add” rating on shares of Synergy Health Plc in a research note on Friday. They now have a GBX 1,380 ($23.24) price target on the stock. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company’s stock. Synergy Health Plc has a consensus rating of “Hold” and an average target price of GBX 1,217.14 ($20.50).
Synergy Health plc delivers a range of specialist outsourced services to healthcare providers and other customers concerned with health management.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.